Advertisement

Heska Corporation HSKA

Set alert

Price alert · HSKA

All alert types
119.99 +119.99 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
1.31B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
799.93
Beta
1.60
Short ratio
5.41
Inst. own
87.54%
Dividend
0.00
Ex-div date
Sep 25, 2012
Earnings
May 5, 2023
50-d avg
117.55
200-d avg
87.11
1y target
130.00

2Y chart

Chart tools
Interval

Events in this range
  • Feb 28, 2022Earnings: —; estimate 0.32; surprise —%
  • May 9, 2022Earnings: —; estimate 0.41; surprise —%
  • Aug 8, 2022Earnings: —; estimate 0.37; surprise —%
  • Oct 17, 2022Rating: JP Morgan · — → Overweight
  • Nov 8, 2022Earnings: —; estimate 0.45; surprise —%
  • Nov 9, 2022Rating: Alliance Global Partners · — → Buy
  • Nov 9, 2022Rating: Morgan Stanley · — → Equal-Weight
  • Nov 14, 2022Rating: Piper Sandler · — → Overweight
  • Jan 6, 2023Downgrade: Morgan Stanley · Equal-Weight → Underweight
  • Feb 28, 2023Earnings: —; estimate 0.38; surprise —%
  • Apr 4, 2023Rating: Morgan Stanley · — → Equal-Weight
  • May 5, 2023Earnings: —; estimate 0.32; surprise —%
Signals (75)
NameDateAgo
MACD: Sell SignalJun 8, 20233 years ago
MACD: Buy SignalJun 5, 20233 years ago
RSI: OverboughtMay 30, 20233 years ago
MACD: Sell SignalApr 20, 20233 years ago
RSI: OverboughtMar 31, 20233 years ago
MACD: Buy SignalMar 16, 20233 years ago
MACD: Sell SignalMar 10, 20233 years ago
MACD: Buy SignalMar 3, 20233 years ago
SMA: BullishFeb 28, 20233 years ago
SMA: BearishFeb 24, 20233 years ago
SMA: BullishFeb 23, 20233 years ago
SMA: BearishFeb 17, 20233 years ago
SMA: BullishFeb 15, 20233 years ago
SMA: BearishFeb 9, 20233 years ago
MACD: Sell SignalFeb 6, 20233 years ago
RSI: OverboughtJan 31, 20233 years ago
SMA: BullishJan 26, 20233 years ago
RSI: OverboughtJan 26, 20233 years ago
SMA: BearishJan 25, 20233 years ago
SMA: BullishJan 23, 20233 years ago
RSI: OverboughtJan 13, 20233 years ago
SMA: BullishJan 9, 20233 years ago
MACD: Buy SignalDec 27, 20223 years ago
MACD: Sell SignalDec 19, 20223 years ago
MACD: Buy SignalDec 1, 20223 years ago
MACD: Sell SignalNov 21, 20223 years ago
MACD: Buy SignalNov 10, 20223 years ago
MACD: Sell SignalNov 4, 20223 years ago
MACD: Buy SignalOct 17, 20224 years ago
MACD: Sell SignalOct 11, 20224 years ago
MACD: Buy SignalOct 7, 20224 years ago
SMA: BearishSep 16, 20224 years ago
SMA: BullishSep 15, 20224 years ago
SMA: BearishSep 13, 20224 years ago
MACD: Sell SignalSep 13, 20224 years ago
MACD: Buy SignalSep 12, 20224 years ago
SMA: BullishSep 9, 20224 years ago
SMA: BearishSep 1, 20224 years ago
MACD: Sell SignalAug 31, 20224 years ago
SMA: BullishAug 23, 20224 years ago
SMA: BearishAug 22, 20224 years ago
SMA: BullishAug 15, 20224 years ago
SMA: BearishAug 12, 20224 years ago
SMA: BullishAug 10, 20224 years ago
SMA: BearishAug 4, 20224 years ago
SMA: BullishAug 3, 20224 years ago
MACD: Buy SignalJul 27, 20224 years ago
MACD: Sell SignalJul 14, 20224 years ago
SMA: BearishJul 11, 20224 years ago
SMA: BullishJul 7, 20224 years ago
MACD: Buy SignalJun 22, 20224 years ago
RSI: OversoldJun 17, 20224 years ago
MACD: Sell SignalJun 14, 20224 years ago
MACD: Buy SignalMay 19, 20224 years ago
RSI: OversoldMay 5, 20224 years ago
RSI: OversoldApr 28, 20224 years ago
SMA: BearishApr 14, 20224 years ago
SMA: BullishApr 13, 20224 years ago
SMA: BearishApr 12, 20224 years ago
MACD: Sell SignalApr 12, 20224 years ago
SMA: BullishApr 1, 20224 years ago
MACD: Buy SignalApr 1, 20224 years ago
SMA: BearishMar 23, 20224 years ago
SMA: BullishMar 22, 20224 years ago
SMA: BearishMar 21, 20224 years ago
MACD: Sell SignalMar 21, 20224 years ago
SMA: BullishMar 18, 20224 years ago
MACD: Buy SignalMar 18, 20224 years ago
MACD: Sell SignalMar 17, 20224 years ago
SMA: BearishMar 16, 20224 years ago
SMA: BullishMar 15, 20224 years ago
SMA: BearishMar 14, 20224 years ago
SMA: BullishMar 4, 20224 years ago
MACD: Buy SignalFeb 8, 20224 years ago
MACD: Sell SignalJan 5, 20224 years ago

Key statistics

Market cap
1.31B
Enterprise value
1.29B
Trailing P/E
0.00
Forward P/E
799.93
PEG ratio
-5.71
Price / sales
5.14
Price / book
3.14
EPS (TTM)
-1.92
Beta
1.60
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-7.86%
Revenue (TTM)
254.89M
Revenue growth
-3.70%
Free cash flow
-5.78M
Total cash
125.21M
Total debt
109.92M
Return on equity
-4.73%
Shares outstanding
10.91M
Short % of float
16.75%
50-day average
117.55
200-day average
87.11

Analyst view

Consensus: buy

Buy
Price target (mean) 130.00 +8.3% upside
Target (low)
120.00
Target (mean)
130.00
Target (high)
150.00
Ratings (0m) 8 4 buy · 4 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

May 5, 2023

Expected May 5, 2023. Consensus EPS estimate -0.22.

Earnings history

Financials — quick view

All financials
HSKA Revenue — quarterly 62.38M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 2023
HSKA Net income — quarterly -10.13M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 2023
HSKA EPS — quarterly -0.97
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 2023

Earnings

HSKA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 5, 2023Mar 1, 20230.32———
Feb 28, 2023Dec 1, 20220.38———
Nov 8, 2022Sep 1, 20220.45———
Aug 8, 2022Jun 1, 20220.37———
May 9, 2022Mar 1, 20220.41———
Feb 28, 2022Dec 1, 20210.32———

Upgrades / downgrades

HSKA analyst upgrades and downgrades
DateFirmActionFromTo
Apr 4, 2023Morgan Stanleymain—Equal-Weight
Jan 6, 2023Morgan StanleydownEqual-WeightUnderweight
Nov 14, 2022Piper Sandlermain—Overweight
Nov 9, 2022Morgan Stanleymain—Equal-Weight
Nov 9, 2022Alliance Global Partnersmain—Buy
Oct 17, 2022JP Morganmain—Overweight

About Heska Corporation

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
heska.com

News

Your note

Sign in to keep a note on HSKA — it syncs with the Stock Master app.

Insider holders

HSKA insider holders
InsiderRelationLatest transactionDateShares held
ANTIN ROBERT LDirectorStock Award(Grant)May 3, 20222,189
BAKER ELEANOR FOfficerStock Award(Grant)Jun 12, 20230
EYL STEVEN MOfficerStock Award(Grant)Mar 23, 202326,904
FURLONG MARK FDirectorStock Award(Grant)May 3, 20224,726
GRASSMAN CATHERINE IChief Financial OfficerStock Award(Grant)May 31, 202314,261
LARSON SHARON J.DirectorStock Award(Grant)May 3, 20228,608

Institution ownership

HSKA institution ownership
Holder% heldSharesValueReported
Blackrock Inc.17.13%1,869,493224.32MMar 30, 2023
Nine Ten Capital Management LLC8.03%876,008105.11MMar 30, 2023
Fred Alger Management, LLC7.59%828,86899.46MMar 30, 2023
Vanguard Group, Inc. (The)6.70%730,93987.71MMar 30, 2023
Ameriprise Financial, Inc.5.29%577,37569.28MMar 30, 2023
State Street Corporation3.98%434,46452.13MMar 30, 2023

Fund ownership

HSKA fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF7.07%768,98092.27MFeb 27, 2023
Alger Small Cap Focus Fund6.56%713,59385.62MJan 30, 2023
Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I3.45%375,20845.02MFeb 27, 2023
Vanguard Total Stock Market Index Fund2.85%309,78437.17MDec 30, 2022
iShares Russell 2000 ETF1.94%211,31825.36MFeb 27, 2023
iShares S&P Smallcap 600 Value ETF1.68%182,15921.86MFeb 27, 2023
Advertisement